Psychosocial and Clinical Characteristics Predicting Women's Acceptance of Office Hysteroscopy

January 31, 2017 updated by: Antonio paulo, Centro Hospitalar Tondela-Viseu

Psychosocial and Clinical Characteristics Predicting Women's Acceptance of Office Hysteroscopy: An Observational Study

Study type:

Observational, prospective.

Objectives:

Primary:

Identify psychosocial and clinical factors that predispose to the occurrence of pain following office hysteroscopy

Secondary:

Stratify risk factors for pain previous Cesarean section and pain score repeat C section and pain score post-menopausal and pain score type of delivery and pain score body mass index and pain score history of dysmenorrhea and pain score, abnormal uterine bleeding and pain score previous surgery upon uterine cervix and pain score Characterize women's psychosocial profile and pain score Establish anxiety as a factor influencing pain perception using (State-Trait Anxiety Inventory for Adults).

Determine if there is a specified population who would benefit from procedure under anaesthesia

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Authors tend to compare pain in hysteroscopy in groups by scope size and variation in technique (e.g. 3mm versus 5mm scopes; vaginoscopic versus traditional speculum insertion approach), so score results reflect relative improvement in tolerability between groups, and they do not have as control an examination expected to be free of suffering.

To the investigators' knowledge there has to date never been an adequate judgement of the proportion of women in the group where pain is felt and should therefore be expected. Focus has always been put on the group of patients who are pain free (or where it is deemed acceptable).

Stating office hysteroscopy is painless because VAS score is halved by miniaturization seems an arbitrary statement for a small, but never the less important group of women.

It should be interesting to investigate factors which might contribute to pain in office hysteroscopy despite the fact the majority of the group will bear mild or no pain. The investigator believes that although reduction of scope size has brought about significant reduction in distress, it remains a painful procedure for some patients and therefore subjecting them to this ordeal may be regarded as an aggression; pain control interventions to reduce suffering might be considered (anxiolytic drugs, local, para-cervical or even general anaesthesia could be of interest in selected cases).

Study Type

Observational

Enrollment (Actual)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Viseu, Portugal, 3500
        • Centro Hospitalar Tondela Viseu

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

All adult women scheduled for office hysteroscopy.

Eligibility criteria and informed consent:

Written informed consent; diagnosis of uterine abnormal bleeding, sonographic evidence of thickened endometrium, sterility workup, endometrial polyps or sub mucous myoma, foreign body extraction or insertion (i.e. sterilization) or other condition with indication for procedure and who meet study eligibility criteria; ability to fill in the study questionnaires

Description

Inclusion Criteria:

  • women scheduled for office hysteroscopy Written informed consent; diagnosis of uterine abnormal bleeding, sonographic evidence of thickened endometrium, sterility workup, endometrial polyps or sub mucous myoma, foreign body extraction or insertion (i.e. sterilization) or other condition with indication for procedure and who meet study eligibility criteria; ability to fill in the study questionnaires.

Exclusion Criteria:

  • refusal to participate in study innability to fill in the study questionnaires

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
office hysteroscopy in Nuligest
Time Frame: five to ten minutes after hystersocopy
Pain score evaluated on a 10cm visual analogue scale
five to ten minutes after hystersocopy
office hysteroscopy in parous women
Time Frame: five to ten minutes after hystersocopy
Pain score evaluated on a 10cm visual analogue scale
five to ten minutes after hystersocopy
office hysteroscopy in previous C section and repeat C section
Time Frame: five to ten minutes after hystersocopy
Pain score evaluated on a 10cm visual analogue scale
five to ten minutes after hystersocopy

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
office hysteroscopy in post-menopausal women
Time Frame: five to ten minutes after hystersocopy
Pain evaluated on a 10cm visual analogue scale
five to ten minutes after hystersocopy
office hysteroscopy and body mass index
Time Frame: five to ten minutes after hystersocopy
Pain evaluated on a 10cm visual analogue scale
five to ten minutes after hystersocopy
office hysteroscopy and psychosocial profile (State-Trait Anxiety Inventory for Adults)
Time Frame: five to ten minutes after hystersocopy
Pain evaluated on a 10cm visual analogue scale
five to ten minutes after hystersocopy
Women's Satisfaction with office hysteroscopy according to pain perceived
Time Frame: five to ten minutes after hystersocopy
Pain evaluated on a 10cm visual analogue scale and satisfaction questionnaires
five to ten minutes after hystersocopy
office hysteroscopy in women with history of dysmenorrhea
Time Frame: five to ten minutes after hystersocopy
Pain evaluated on a 10cm visual analogue scale
five to ten minutes after hystersocopy
office hysteroscopy in women with abnormal uterine bleeding
Time Frame: five to ten minutes after hystersocopy
Pain evaluated on a 10cm visual analogue scale
five to ten minutes after hystersocopy
office hysteroscopy in women with previous surgery upon uterine cervix
Time Frame: five to ten minutes after hystersocopy
Pain evaluated on a 10cm visual analogue scale
five to ten minutes after hystersocopy

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Antonio Paulo, MD, Centro Hospitalar Tondela-Viseu

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2015

Primary Completion (Actual)

September 1, 2015

Study Completion (Actual)

November 1, 2015

Study Registration Dates

First Submitted

August 29, 2015

First Submitted That Met QC Criteria

September 4, 2015

First Posted (Estimate)

September 7, 2015

Study Record Updates

Last Update Posted (Estimate)

February 2, 2017

Last Update Submitted That Met QC Criteria

January 31, 2017

Last Verified

January 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • ASP/asp

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pelvic Girdle Pain

Clinical Trials on office hysteroscopy

Subscribe